Search
Integra Lifesciences Holdings Corp
IARTAdd to Watchlist
15.120USD
-0.100-0.66%
Market hours 09/21, 09:31（ET）
1.18BMarket Cap
LossP/E TTM
Integra Lifesciences Holdings Corp (IART) Revenue Performance
Updated: Jun 30, 2026Last year, Integra Lifesciences Holdings Corp generated 827.67M USD for its biggest-performing segment, Neurosurgery. The United States made the largest contribution, accounting for 1.20B USD last year. For the latest quarter, Integra Lifesciences Holdings Corp reported the revenue of 213.26M USD for the period ending 2026-06-30, which came from the top-performing segment, Neurosurgery. United States contributed the highest revenue, at 307.10M USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Neurosurgery
Wound Reconstruction and Care
Instruments
ENT
Private Label
Extremity Orthopedics
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Neurosurgery
827.67M(50.61%)
803.82M(49.91%)
818.10M(53.07%)
794.02M(50.97%)
802.96M(52.06%)
716.34M(52.22%)
707.01M(46.59%)
Wound Reconstruction and Care
323.49M(19.78%)
350.56M(21.77%)
373.99M(24.26%)
406.69M(26.11%)
392.46M(25.44%)
293.04M(21.36%)
322.74M(21.27%)
Instruments
206.47M(12.63%)
204.18M(12.68%)
240.89M(15.63%)
225.55M(14.48%)
222.27M(14.41%)
178.49M(13.01%)
289.19M(19.06%)
ENT
166.37M(10.17%)
135.64M(8.42%)
--(--)
--(--)
--(--)
--(--)
--(--)
Private Label
111.25M(6.80%)
116.33M(7.22%)
108.59M(7.04%)
131.41M(8.44%)
124.75M(8.09%)
105.68M(7.70%)
108.53M(7.15%)
Extremity Orthopedics
--(--)
--(--)
--(--)
--(--)
--(--)
78.32M(5.71%)
90.08M(5.94%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
Asia Pacific
Europe
Rest of World
Asia/Pacific
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
United States
1.20B(73.67%)
1.19B(66.74%)
1.10B(63.45%)
1.13B(72.34%)
1.09B(70.64%)
971.98M(70.85%)
1.08B(70.99%)
Asia Pacific
189.25M(11.57%)
176.61M(9.88%)
193.10M(11.13%)
--(--)
--(--)
--(--)
--(--)
Europe
162.67M(9.95%)
158.50M(8.87%)
165.22M(9.52%)
170.90M(10.97%)
191.33M(12.40%)
172.69M(12.59%)
197.47M(13.01%)
Rest of World
78.58M(4.81%)
82.74M(4.63%)
82.53M(4.76%)
83.48M(5.36%)
79.56M(5.16%)
70.03M(5.10%)
85.32M(5.62%)
Asia/Pacific
--(--)
176.61M(9.88%)
193.10M(11.13%)
176.48M(11.33%)
182.03M(11.80%)
157.17M(11.46%)
157.39M(10.37%)